• Eli Lilly and Company
• Innovent Biologics
• Novo Nordisk
• AstraZeneca
• Biolingus
• D and D Pharmatech
• Terns Pharmaceuticals
• i2O Therapeutics
Published | Pages | Publisher | Report code |
---|---|---|---|
Mar 2021 | 100 | DelveInsight | ASDR-575663 |
• Eli Lilly and Company
• Innovent Biologics
• Novo Nordisk
• AstraZeneca
• Biolingus
• D and D Pharmatech
• Terns Pharmaceuticals
• i2O Therapeutics